The LYCRA Company Names Melissa Riggs as Chief Marketing Officer

 (BUSINESS WIRE)--The LYCRA Company, a global leader in developing sustainable and innovative fiber and technology solutions for the apparel and personal care industries, today announced that Melissa Riggs, director of marketing, North America, has been promoted to the role of chief marketing officer (CMO).

Riggs brings more than two decades of brand-building experience in consumer packaged goods and the apparel and footwear industries to her new role, including experience with the GORE-TEX brand. Before joining The LYCRA Company in 2022, Riggs spent 11 years at Molson Coors Beverage Company, specializing in partnership marketing and distributor go-to-market planning.

“I am pleased to recognize exceptional talent from within our organization,” said Gary Smith, The LYCRA Company’s CEO. “Melissa’s promotion reflects the importance we place on building upon our company’s unique marketing capability and the value it brings to our customers.”

As CMO of The LYCRA Company, Riggs oversees the planning, development, and execution of brand and marketing initiatives supporting the company’s business objectives and growth strategies.

“I am honored and excited to lead The LYCRA Company’s marketing organization and work with the global leadership team to help the company achieve its goals,” said Riggs. "For the past three years, I’ve had the privilege of collaborating with an incredibly skilled team. Stepping into the CMO role, I look forward to unlocking new ways to invigorate our ingredient brands, elevate our partners, and make our impact felt throughout the value chain.”

Riggs has a master’s degree from Temple University in Philadelphia and a bachelor’s degree from the University of Rhode Island in Kingston. She is based out of The LYCRA Company’s headquarters in Wilmington, Delaware, reporting directly to Smith.

About The LYCRA Company

The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries and owns the leading consumer brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL®. Headquartered in Wilmington, Delaware, U.S., The LYCRA Company is recognized worldwide for its sustainable products, technical expertise, and marketing support. The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit lycra.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250501847722/en/

Permalink

https://www.aetoswire.com/en/news/54247085

Contacts

Karie J. Ford

Karie.j.ford@lycra.com

From Scalable Solutions to Full-Stack AI Infrastructure, GIGABYTE to Present End-to-End AI Portfolio at COMPUTEX 2025

TAIPEI - Thursday, 01. May 2025

(BUSINESS WIRE)--GIGABYTE Technology, a global leader in computing innovation, will return to COMPUTEX 2025 from May 20 to 23 under the theme "Omnipresence of Computing: AI Forward." Demonstrating how GIGABYTE’s complete spectrum of solutions spanning the AI lifecycle, from data center training to edge deployment and end-user applications reshapes the infrastructure to meet the next-gen AI demands.

As generative AI continues to evolve, so do the demands for handling massive token volumes, real-time data streaming, and high-throughput compute environments. GIGABYTE’s end-to-end portfolio - ranging from rack-scale infrastructure to servers, cooling systems, embedded platforms, and personal computing—forms the foundation to accelerate AI breakthroughs across industries.

Scalable AI Infrastructure Starts Here: GIGAPOD with GPM Integration

At the heart of GIGABYTE exhibit is the enhanced GIGAPOD, a scalable GPU cluster designed for high-density data center and large AI model training. Designed for high-performance AI workloads, GIGAPOD supports the latest accelerating platforms including AMD Instinct™ MI325X and NVIDIA HGX™ H200. It is now integrated with GPM (GIGABYTE POD Manager), GIGABYTE’s proprietary infra and workflow management platform, which can enhance operational efficiency, streamline management, and optimize resource utilization across large-scale AI environments.

This year will also see the debut of the GIGAPOD Direct Liquid Cooling (DLC) variant, incorporating GIGABYTE’s G4L3 series servers and engineered for next-gen chips with TDPs exceeding 1,000W. The DLC solution is demonstrated in a 4+1 rack configuration in partnership with Kenmec, Vertiv, and nVent, featuring integrated cooling, power distribution, and network architecture. To help customers deploy faster and smarter, GIGABYTE offers end-to-end consulting services, including planning, deployment, and system validation, accelerating the path from concept to operation.

Built for Deployment: From Super Compute Module to Open Compute and Custom Workloads

As AI adoption shifts from training to deployment, GIGABYTE’s flexible system design and architecture ensure seamless transition and expansion. GIGABYTE presents the cutting-edge NVIDIA GB300 NVL72, a fully liquid-cooled, rack-scale design that unifies 72 NVIDIA Blackwell Ultra GPUs and 36 Arm®-based NVIDIA Grace™ CPUs in a single platform optimized for test-time scaling inference. Also shown at the booth are two OCP-compliant server racks: an 8OU AI system with NVIDIA HGX™ B200 integrated with Intel® Xeon® processors, and an ORV3 CPU-based storage rack with JBOD design to maximize density and throughput.

GIGABYTE also exhibits modular and diverse servers from high-performance GPU to storage-optimized to meet different AI workloads:

Accelerated Compute: Air- and liquid-cooled servers for the latest AMD Instinct™MI325X, Intel® Gaudi® 3, and NVIDIA HGX™ B300 GPU platforms, optimized for GPU-to-GPU interconnects

CXL Technology: CXL-enabled systems unlock shared memory pools across CPUs for real-time AI inference

High-density Compute & Storage: Multi-node servers packed with high-core count CPUs and NVMe/E1.S storage, developed in collaboration with Solidigm, ADATA, Kioxia, and Seagate

Cloud & Edge Platforms: Blade and node solutions optimized for power, thermal efficiency, and workload diversity—ideal for hyperscalers and managed service providers

Bringing AI to the Edge—and to Everyone

Extending AI to real-world applications, GIGABYTE introduces a new generation of embedded systems and mini PCs that bring compute closer to where data is generated.

Jetson-Powered Embedded Systems: Featuring NVIDIA® Jetson Orin™, these rugged platforms power real-time edge AI in industrial automation, robotics, and machine vision.

BRIX Mini PCs: Compact yet powerful, the latest BRIX systems include onboard NPUs and support Microsoft Copilot+ and Adobe AI tools, perfect for lightweight AI inference at the edge.

Expanding leadership from cloud to the edge, GIGABYTE delivers powerful on-premises AI acceleration with our advanced Z890/X870 motherboards and cutting-edge GeForce RTX 50 and Radeon RX 9000 Series graphics cards. The innovative AI TOP local AI computing solution simplifies complex AI workflows through memory offloading and multi-node clustering capabilities. This AI innovation extends throughout our consumer lineup - from Microsoft-certified Copilot+ AI PCs and gaming powerhouses to high-refresh OLED monitors. On laptops, the exclusive "Press and Speak" GIMATE AI agent enables intuitive hardware control, enhancing both productivity and everyday AI experiences.

GIGABYTE invites everyone to explore the AI Forward era, defined by scalable architecture, precision engineering, and a commitment to accelerating progress.

https://www.gigabyte.com/Events/Computex

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250428101781/en/

Permalink

https://www.aetoswire.com/en/news/1052025463100

Contacts

Michael Pao brand@GIGABYTE.com

Boomi CEO Steve Lucas’ New Book ‘Digital Impact’ Becomes a National Bestseller, Topping USA Today and Publishers Weekly Lists

 CONSHOHOCKEN, Pa. - Tuesday, 29. April 2025

“Digital Impact: The Human Element of AI-Driven Transformation” earns top rankings as business leaders embrace its timely message on the responsible use of AI

 

(BUSINESS WIRE)--Boomi™, the intelligent integration and automation leader, today announced that Chairman and CEO Steve Lucas is now a national bestselling author with the release of his new book, Digital Impact: The Human Element of AI-Driven Transformation (Wiley). Since its debut, the book has rapidly climbed national bestseller charts — including multiple appearances on USA TODAY’s Bestselling Books lists, and Publishers Weekly Bestseller List. Digital Impact resonates deeply with business leaders navigating the intersection of AI and human-centered innovation, offering a timely blueprint for more thoughtful, effective digital transformation.

With AI continuing to dominate executive agendas, Digital Impact offers a fresh perspective — one that emphasizes empathy, trust, and responsibility alongside innovation and speed. Lucas draws on decades of leadership experience to deliver an actionable roadmap for organizations looking to unlock the value of AI while staying grounded in human values.

“Becoming a national bestseller is an incredible honor, but more importantly, it shows how urgent and universal this conversation has become,” Lucas said. “AI is transforming business at an unprecedented pace. Digital Impact is a call to action for leaders to ensure that transformation is guided by purpose, ethics, and a focus on people.”

Following its recent debut, Digital Impact has achieved remarkable early momentum across national bestseller lists, including:

#11 on USA TODAY’s Bestselling Book List (Overall)

Digital Impact made a stunning debut, ranking #11 across all categories on USA TODAY’s national Bestselling Book List — an incredible achievement that reflects the book’s broad appeal beyond just the business and tech world.

#5 on USA TODAY’s Bestselling List for Nonfiction

Among all nonfiction titles, Digital Impact entered the charts at #5, positioned alongside some of the most influential thought leadership and current affairs titles in the country.

#3 on USA TODAY’s Bestselling List for Business Books

The book secured the #3 spot among business books, underscoring its relevance for today’s leaders looking to understand and navigate AI-driven transformation with a human-first mindset.

#18 on Publishers Weekly Hardcover Nonfiction Bestseller List

In its first week of eligibility, Digital Impact also made its debut at #18 on Publishers Weekly’s Hardcover Nonfiction Bestseller List, a trusted benchmark for the publishing industry that reflects strong sales performance and national traction.

Early praise for the book highlights its relevance in today’s AI-driven world, with executives, CIOs, and tech influencers citing Digital Impact as a must-read for anyone navigating digital change.

The book is now available at major retailers, including Amazon, Barnes & Noble, and Books-A-Million.

To learn more, visit: boomi.com/digitalimpact

About Boomi

Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.

© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429280721/en/

Permalink

https://aetoswire.com/en/news/2904202546262

Contacts

Media Contacts:

Kristen Walker | (415) 613-8320 | kristenwalker@boomi.com

David Wolpert | (972) 743-8477 | david@fortierpr.com

 

Andersen Consulting Expands Capabilities in Brazil

 (BUSINESS WIRE) -- Following the recent global launch of Andersen Consulting in February, the organization expands its consulting capabilities in Brazil as Albieri e Associados becomes a member of Andersen Consulting.

Albieri e Associados, formerly a collaborating firm of Andersen Global since 2019, brings a robust portfolio of capabilities to Andersen’s consulting platform, specializing in areas such as strategic consulting, financial management, operational optimization, and business transformation. The firm works closely with clients across various sectors to drive innovation, improve performance, and navigate complex business challenges.

Luiz Albieri, managing partner of Albieri e Associados, said, “Becoming a member of Andersen Consulting opens up new opportunities for us to offer even more solutions to our clients while leveraging Andersen’s global platform. We already have strong working relationships with the member and collaborating firms of Andersen Global and look forward to working with the members of Andersen Consulting globally to further elevate the value we deliver to businesses in Brazil and internationally.”

Mark L. Vorsatz, global chairman and CEO of Andersen, added, “Albieri e Associados’ knowledge of the Brazilian market, coupled with their familiarity of the Andersen organization, strengthens our existing consulting platform in the country. Together, with our other consulting members in Brazil and globally, we will be able to provide our clients with holistic solutions that allow them to become more efficient and competitive in the global marketplace.”

Andersen Consulting is a global consulting practice providing a comprehensive suite of services spanning corporate strategy, business, technology, and AI transformation, as well as human capital solutions. Andersen Consulting integrates with the multidimensional service model of Andersen Global, delivering world-class consulting, tax, legal, valuation, global mobility, and advisory expertise on a global platform with more than 20,000 professionals worldwide and a presence in over 500 locations through its member firms and collaborating firms. Andersen Consulting Holdings LP is a limited partnership and provides consulting solutions through its member firms and collaborating firms around the world.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250430862359/en/

Permalink

https://www.aetoswire.com/en/news/3004202546299

Contacts

mediainquiries@Andersen.com

SINOVAC Announces Record and Distribution Dates for Special Cash Dividend

 BEIJING - 

(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC’s common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc.

The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under “Category 1 Preventative Biological Products” and commercialized in China in 2016. In 2022, SINOVAC’s Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program.

SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations.

For more information, please visit the Company’s website at www.sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon the Company’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing and implementation of the special dividend, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429276960/en/

Permalink

https://www.aetoswire.com/en/news/3004202546276

Contacts

Sinovac Biotech Ltd.

Helen Yang

Tel: +86-10-8279 9779

Email: ir@sinovac.com

U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene

 SAN CARLOS, Calif. -

(BUSINESS WIRE) -- BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding.

On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics.

Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief that Pharmacyclics’ ‘803 patent is overly broad and invalid. BeiGene is confident in the strength of our intellectual property supporting BRUKINSA, a clearly differentiated and independently developed medicine. With approvals in more than 70 countries and regions for the treatment of multiple B-cell malignancies, BRUKINSA continues to set a new standard of care for patients worldwide.”

About BRUKINSA® (zanubrutinib)

BRUKINSA is an orally available, small molecule inhibitor of Bruton’s tyrosine kinase (BTK) designed to deliver complete and sustained inhibition of the BTK protein by optimizing bioavailability, half-life, and selectivity. With differentiated pharmacokinetics compared with other approved BTK inhibitors, BRUKINSA has been demonstrated to inhibit the proliferation of malignant B cells within a number of disease-relevant tissues.

BRUKINSA has the broadest label globally of any BTK inhibitor and is the only BTK inhibitor to provide the flexibility of once or twice daily dosing. The global BRUKINSA clinical development program includes about 7,100 patients enrolled in 30 countries and regions across more than 35 trials. BRUKINSA is approved in more than 70 markets, and more than 180,000 patients have been treated globally.

About BeiGene

BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding the strength of BeiGene’s intellectual property supporting BRUKINSA; BRUKINSA’s ability to set a new standard of care for patients worldwide; and BeiGene’s plans, commitments, aspirations and goals under the caption “About BeiGene”. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including BeiGene’s ability to demonstrate the efficacy and safety of its drug candidates; the clinical results for its drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials and marketing approval; BeiGene’s ability to achieve commercial success for its marketed medicines and drug candidates, if approved; BeiGene’s ability to obtain and maintain protection of intellectual property for its medicines and technology; BeiGene’s reliance on third parties to conduct drug development, manufacturing, commercialization, and other services; BeiGene’s limited experience in obtaining regulatory approvals and commercializing pharmaceutical products; BeiGene’s ability to obtain additional funding for operations and to complete the development of its drug candidates and achieve and maintain profitability; and those risks more fully discussed in the section entitled “Risk Factors” in BeiGene’s most recent annual report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in BeiGene’s subsequent filings with the U.S. Securities and Exchange Commission. All information in this press release is as of the date of this press release, and BeiGene undertakes no duty to update such information unless required by law. BeiGene’s financial guidance is based on estimates and assumptions that are subject to significant uncertainties.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429590949/en/

Permalink

https://www.aetoswire.com/en/news/3004202546268

Contacts

Investor Contact

Liza Heapes

+1 857-302-5663

ir@beigene.com

Media Contact

Kyle Blankenship

+1 667-351-5176

media@beigene.com

 

One out of Three Secure Civil IDs Delivered Each Year Is Powered by Thales

 

• In a world where identity fraud represents a critical vulnerability for citizens and societies, Thales is leading the transformation of civil identity into a secure and citizen-first service.
• Through its advanced Civil Identity Suite, Thales enables governments worldwide to protect their citizens, ensuring protection at every stage of the identity journey and for the entire identity chain.
• Supporting more than 300 national identity programmes and having enrolled over 500 million people, Thales is uniquely positioned to deliver secure and responsible identity solutions.

 

(BUSINESS WIRE)--Each year, Thales powers one in three smart civil IDs (official electronic documents) issued worldwide, highlighting the company’s key role in shaping the future of identities and helping governments and citizens transition smoothly to digital. With its Civil Identity Suite, Thales enables the issuance and management of both physical and digital identities, as well as all means of enrolling citizens and enabling seamless ID verification for access to services, both in-person and online.

Thales, a global leader in advanced technologies and #1 global leader in ID documents, has recently earned the new title of #1 provider of Digital ID solutions as recognized by Juniper Research (2024). With unmatched experience and scale, Thales empowers governments to modernise their identity systems, ensuring they meet the demands of 21st-century citizens with trust and reliability.

Holistic security for the entire identity chain

At a time when identity theft is a real threat, providing a trusted and easy-to-use identity solution is more critical than ever. In response, Thales’s Civil Identity Suite integrates advanced cybersecurity across the entire identity lifecycle. Real-time threat detection, vulnerability management, and automated incident response protect sensitive citizen data from cyberattacks. AI-powered biometric authentication, with embedded liveness detection, strengthens fraud resistance by ensuring that only genuine individuals can access services. Both physical and digital credentials are secured with tamper-proof technologies, guaranteeing trust at every step of the identity journey.

Simplifying identity access for citizens everywhere

Identity should be seamless, inclusive, and accessible. Thales Civil Identity Suite offers citizens a convenient experience, enabling them to enrol biometrically in seconds and use their identity easily both online and in person. Citizens can store and access their identity documents digitally, ensuring secure interactions with both government and private sector services. Indeed, Thales also enables banks and mobile operators to remotely enrol customers through a secure, government-grade ID verification process. To enable such a seamless way for people to prove who they are - even from their smartphone - the Civil Identity Suite is built on a fully interoperable, modular architecture. It allows governments to scale and integrate new capabilities seamlessly, while enabling private sector entities to expand their digital services leveraging a trusted, verified ID.

"In today’s digital world, identity is more than just a credential—it’s the key to secure seamless access to essential services. At Thales, we are committed to providing trusted identity solutions that empower citizens with security, convenience, and control over their personal data. By combining physical and digital identity with cutting-edge security, we help governments build robust and sustainable identity ecosystems that enhance public trust, streamline services, and drive digital inclusion", said Nathalie Gosset, VP Identity & Biometric Solutions at Thales.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies for the Defence, Aerospace, and Cyber & Digital sectors. Its portfolio of innovative products and services addresses several major challenges: sovereignty, security, sustainability and inclusion.
The Group invests more than €4 billion per year in Research & Development in key areas, particularly for critical environments, such as Artificial Intelligence, cybersecurity, quantum and cloud technologies.
Thales has more than 83,000 employees in 68 countries. In 2024, the Group generated sales of €20.6 billion.

PLEASE VISIT
Thales Group
Download HD photos

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429687137/en/

Permalink
https://www.aetoswire.com/en/news/2904202546266

Contacts

PRESS

Thales, Media Relations:
Vanessa Viala
Press Officer – Cyber & Digital
vanessa.viala@thalesgroup.com